Markets:

Overview

News

Currencies

International

Treasuries

Ensysce Biosciences, Inc. - Common Stock (NQ:ENSC)

0.3060 -0.0126 (-3.95%)

Streaming Delayed Price Updated: 10:32 AM EDT, May 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ensysce Biosciences, Inc. - Common Stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday ↗

July 05, 2022

Gainers Omeros Corporation (NASDAQ: OMER) jumped 68.7% to close at $4.64. Clovis Oncology, Inc. (NASDAQ: CLVS) gained 58.3% to settle at $2.85 on Friday.

Via Benzinga

Why Is Akebia Therapeutics Surging By 28%? 48 Stocks Moving In Friday's Mid-Day Session ↗

July 01, 2022

Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 56.1% to $ 0.7029 after dropping 10% on Thursday.

Via Benzinga

Why Is Akebia Therapeutics (AKBA) Stock Up 14% Today? ↗

July 01, 2022

Akebia Therapeutics (AKBA) stock is taking off on Friday after the kidney treatment company revealed the return of rights for vadadustat.

Via InvestorPlace

Why Is Ensyce Biosciences (ENSC) Stock Down 27% Today? ↗

July 01, 2022

Ensyce Biosciences (ENSC) stock is taking a beating on Friday after the clinical-stage biotech company announced $8 million in financing.

Via InvestorPlace

Ensysce Biosciences Secures $8 Million Convertible Note Financing

July 01, 2022

~ Additional Funding from Investor Cohort Validates Company's Mission ~

From Ensysce Biosciences, Inc.

Via AccessWire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 01, 2022

Via Benzinga

Akebia Therapeutics And 20 Stocks Moving Premarket ↗

July 01, 2022

Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 83.2% to $0.8250 in pre-market trading after dropping 10% on Thursday.

Via Benzinga

Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday ↗

July 01, 2022

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase...

Via Benzinga

Ensysce Biosciences Receives Notice of Award for 4th Year of Funding for Its Multi-Pill Abuse Resistance (MPAR(TM)) Platform

June 27, 2022

SAN DIEGO, CA / ACCESSWIRE / June 27, 2022 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC) (OTC:ENSCW), a clinical-stage biotech company applying transformative chemistry to...

From Ensysce Biosciences, Inc.

Via AccessWire

Ensysce Biosciences Reminds Shareholders to Vote At Upcoming 2022 Virtual Annual Shareholder Meeting

June 21, 2022

- Shareholder Meeting to be Held on Thursday, June 23rd at 9:00 AM PT

From Ensysce Biosciences, Inc.

Via AccessWire

Topics Death Intellectual Property

The Daily Biotech Pulse: INmune Bio's Planned Alzheimer's Trial On FDA Hold, Caladrius Stops Enrollment In Heart Disease Study, BiomX Restructures ↗

May 24, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Ensysce Biosciences Announces Initiation of First Human Abuse Potential Study

May 23, 2022

~ Nasal Opioid Abuse Being Explored for PF614 ~

From Ensysce Biosciences, Inc.

Via AccessWire

Ensysce Biosciences Provides Business Update and Reports First Quarter 2022 Financial Results

May 12, 2022

Corporate Update Call to be Held Tuesday, May 17, 2022 SAN DIEGO, CA / ACCESSWIRE / May 12, 2022 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC)(OTC PINK:ENSCW), a clinical-stage...

From Ensysce Biosciences, Inc.

Via AccessWire

Ensysce Biosciences Releases 2021 Annual Shareholder Letter

May 05, 2022

Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.

From Ensysce Biosciences, Inc.

Via AccessWire

Topics Death Intellectual Property Regulatory Compliance

Global Antibiotic Resistance Market to Hit US$16.5 Billion By 2030

April 21, 2022

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 21, 2022 – Resistance to antibiotics is a growing concern. About 750,000 people die each year worldwide from...

Via FinancialNewsMedia

Dr. Lynn Kirkpatrick, Invited Speaker at SMi 22nd Annual Pain Therapeutics Conference in London UK

April 20, 2022

SAN DIEGO, CA / ACCESSWIRE / April 20, 2022 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC)(OTC PINK:ENSCW), a clinical-stage biotech company applying transformative chemistry to...

From Ensysce Biosciences, Inc.

Via AccessWire

Ensysce Biosciences Announces Appointment of Dr. Nily Osman as Chief Medical Officer

April 18, 2022

SAN DIEGO, CA / ACCESSWIRE / April 18, 2022 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC)(OTC PINK:ENSCW), a clinical-stage biotech company applying transformative chemistry to...

From Ensysce Biosciences, Inc.

Via AccessWire

51 Biggest Movers From Yesterday ↗

April 06, 2022

Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares surged 148.2% to close at $5.61 on Tuesday after the company announced that two of its designed mRNA molecules are...

Via Benzinga

Earnings Scheduled For March 31, 2022 ↗

March 31, 2022

Companies Reporting Before The Bell • Trevena (NASDAQ:TRVN) is likely to report earnings for its fourth quarter.

Via Benzinga

Ensysce Biosciences Announces Fourth Quarter and Full Year 2021 Earnings Release Date and Timing of Corporate Update Call

March 24, 2022

SAN DIEGO, CA / ACCESSWIRE / March 24, 2022 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC)(OTC PINK:ENSCW), a clinical-stage biotech company applying transformative chemistry to...

From Ensysce Biosciences, Inc.

Via AccessWire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 07, 2022

Gainers TherapeuticsMD (NASDAQ:TXMD) stock increased by 56.5% to $0.33 during Monday's pre-market session. The company's market cap stands at $139.7 million....

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

March 07, 2022

Welcome back, trader! Let's get right into it with an overview of the biggest pre-market stock movers for Monday morning!

Via InvestorPlace

42 Stocks Moving in Monday's Pre-Market Session ↗

March 07, 2022

Gainers Nine Energy Service, Inc. (NYSE: NINE) rose 96.7% to $3.54 in pre-market trading after climbing around 43% on Friday. Shares of low-priced energy stocks jumped as...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

February 18, 2022

Gainers HOOKIPA Pharma (NASDAQ:HOOK) stock moved upwards by 27.0% to $2.54 during Friday's regular session. The current volume of 40.0 million shares is 1123.6% of...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

February 11, 2022

Gainers Avenue Therapeutics (NASDAQ:ATXI...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

January 27, 2022

Gainers Avidity Biosciences (NASDAQ:RNA) s...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

January 21, 2022

Gainers Biophytis (NASDAQ:BPTS) shares rose 12.3% to $5.28 during Friday's regular session. The market value of their outstanding shares is at $68.0 million. Intra-...

Via Benzinga

52 Biggest Movers From Yesterday ↗

January 20, 2022

Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares surged 65.7% to close at $25.92 on Wednesday after the company announced it will be acquired by UCB for approximately $1.9 billion. G...

Via Benzinga

35 Stocks Moving In Wednesday's Mid-Day Session ↗

January 19, 2022

Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares jumped 67.1% to $26.15 after the company announced it will be acquired by UCB for approximately $1.9 billion. Splash Beverage Group,...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 19, 2022

Gainers Zogenix (NASDAQ:ZGNX) stock rose 68.2% to $26.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.4 billion. Lucid...

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.